Ronald Goldenberg Selected Research

Ronald Goldenberg Research Topics

Disease

17	Type 2 Diabetes Mellitus (MODY) 07/2023 - 03/2014
6	COVID-19 07/2023 - 01/2020
3	Critical Illness (Critically Ill) 01/2023 - 01/2020
3	Hemorrhage 12/2022 - 01/2020
2	Diabetes Complications 07/2023 - 01/2017
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 12/2022
2	Hypoglycemia (Reactive Hypoglycemia) 11/2020 - 02/2018
2	Body Weight (Weight, Body) 11/2018 - 03/2014
1	Pneumonia (Pneumonitis) 01/2023
1	Bacterial Pneumonia 01/2023
1	Dyspnea (Shortness of Breath) 07/2021
1	Thrombosis (Thrombus) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Cognitive Dysfunction 11/2020
1	Hypersensitivity (Allergy) 11/2020
1	Injection Site Reaction 11/2020
1	Hemolysis 10/2020
1	Infections 10/2020
1	Inflammation (Inflammations) 10/2020
1	Glucosephosphate Dehydrogenase Deficiency 10/2020
1	Coronavirus Infections 10/2020
1	Acute Kidney Injury (Acute Renal Failure) 10/2020
1	Pulmonary Embolism 01/2020
1	Paralysis (Palsy) 01/2020
1	Weight Loss (Weight Reduction) 10/2019
1	Bone Fractures (Bone Fracture) 11/2018
1	Chronic Renal Insufficiency 11/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 10/2018
1	Hyperglycemia 04/2018
1	Hypertension (High Blood Pressure) 03/2014
1	Diabetic Nephropathies (Diabetic Nephropathy) 03/2014
1	Diabetes Mellitus 03/2014
1	Kidney Diseases (Kidney Disease) 03/2014

Drug/Important Bio-Agent (IBA)

9	Insulin (Novolin)FDA Link 01/2023 - 03/2014
5	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2017
4	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 03/2014
3	Dipeptidyl-Peptidase IV InhibitorsIBA 11/2020 - 03/2014
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2022 - 01/2017
2	Insulin Glargine (Lantus)FDA Link 01/2022 - 11/2020
2	Ferritins (Ferritin)IBA 01/2021 - 10/2020
2	fibrin fragment D (D-dimer)IBA 01/2021 - 10/2020
2	C-Reactive ProteinIBA 01/2021 - 10/2020
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 10/2019 - 03/2014
2	dapagliflozinIBA 10/2019 - 11/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	tocilizumab (atlizumab)FDA Link 01/2023
1	InsulinsIBA 12/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 07/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2021
1	insulin icodecIBA 11/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2020
1	Blood Glucose (Blood Sugar)IBA 11/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2020
1	Glutathione (Reduced Glutathione)IBA 10/2020
1	EnzymesIBA 10/2020
1	Oxidoreductases (Dehydrogenase)IBA 10/2020
1	Acetylcysteine (Siran)FDA LinkGeneric 10/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020
1	Liraglutide FDA Link 10/2019
1	MagnesiumIBA 10/2019
1	dulaglutideIBA 10/2019
1	lixisenatideIBA 01/2017
1	2- (2,5- difluorophenyl)- 5- (2- (methylsulfonyl)- 2,6- dihydropyrrolo(3,4- c)pyrazol- 5(4H)- yl)tetrahydro- 2H- pyran- 3- amineIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2014
1	Triglycerides (Triacylglycerol)IBA 03/2014
1	Hemoglobins (Hemoglobin)IBA 03/2014
1	LDL CholesterolIBA 03/2014
1	HDL CholesterolIBA 03/2014
1	IncretinsIBA 03/2014

Therapy/Procedure

5	Therapeutics 01/2023 - 03/2014
4	Artificial Respiration (Mechanical Ventilation) 01/2023 - 01/2020
3	Glycemic Control 04/2018 - 01/2016
2	Injections 12/2021 - 11/2020
2	Tracheostomy 01/2021 - 01/2020
1	Continuity of Patient Care 07/2023
1	Extracorporeal Membrane Oxygenation 12/2022
1	Cannula 12/2022
1	Contraindications 01/2022
1	Hip Replacement Arthroplasty (Total Hip Replacement) 07/2021
1	Membrane Oxygenators (Membrane Oxygenator) 10/2020
1	Critical Care (Surgical Intensive Care) 10/2020
1	Mechanical Ventilators (Ventilator) 10/2020
1	Time-to-Treatment 01/2020
1	Surgical Amputation (Amputations) 11/2018
1	Transjugular Intrahepatic Portasystemic Shunt 10/2018